Ultrastructural Damages to H1N1 Influenza Virus Caused by Vapor Essential Oils.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
09 Jun 2022
Historique:
received: 05 05 2022
revised: 06 06 2022
accepted: 06 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Influenza viruses are transmitted from human to human via airborne droplets and can be transferred through contaminated environmental surfaces. Some works have demonstrated the efficacy of essential oils (EOs) as antimicrobial and antiviral agents, but most of them examined the liquid phases, which are generally toxic for oral applications. In our study, we describe the antiviral activity of

Identifiants

pubmed: 35744845
pii: molecules27123718
doi: 10.3390/molecules27123718
pmc: PMC9230754
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Antiviral Agents 0
Oils, Volatile 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Universities and Research
ID : 2017BMK8JR006
Organisme : Sapienza University of Rome
ID : Ateneo 2020 (for L.N.)
Organisme : Sapienza University of Rome
ID : Ateneo 2020 (for R.C.)
Organisme : Fondazione Cenci Bolognetti Istituto Pasteur Italia
ID : 2019

Références

BMC Complement Altern Med. 2010 Nov 15;10:69
pubmed: 21078173
Phytother Res. 2010 May;24(5):673-9
pubmed: 19653195
Clin Infect Dis. 2010 Nov 1;51(9):1053-61
pubmed: 20879867
Nat Rev Microbiol. 2018 Jan;16(1):47-60
pubmed: 29081496
Int J Environ Res Public Health. 2011 Dec;8(12):4477-87
pubmed: 22408584
Front Cell Infect Microbiol. 2022 Jan 06;11:804976
pubmed: 35071051
Colloids Surf B Biointerfaces. 2005 Jul 10;43(3-4):198-202
pubmed: 15975773
J Ethnopharmacol. 2011 Jun 14;136(1):10-20
pubmed: 21549817
Poult Sci. 2014 Jan;93(1):70-6
pubmed: 24570425
J Infect Chemother. 2001 Dec;7(4):251-4
pubmed: 11810593
J Enzyme Inhib Med Chem. 2017 Dec;32(1):798-804
pubmed: 28569564
Inflammation. 2016 Aug;39(4):1582-93
pubmed: 27351430
Osong Public Health Res Perspect. 2018 Dec;9(6):348-353
pubmed: 30584499
Zoonoses Public Health. 2007;54(2):51-68
pubmed: 17348909
Clin Microbiol Rev. 2006 Jan;19(1):50-62
pubmed: 16418522
Curr Microbiol. 2008 Jan;56(1):89-92
pubmed: 17972131
Flavour Fragr J. 2015 Sep;30(5):331-341
pubmed: 32313366
Plants (Basel). 2022 Mar 16;11(6):
pubmed: 35336671
Pathog Dis. 2016 Jun;74(4):ftw014
pubmed: 26926153
FASEB J. 2021 Feb;35(2):e21358
pubmed: 33538061
Molecules. 2020 Feb 05;25(3):
pubmed: 32033336
Planta Med. 2012 Oct;78(15):1636-8
pubmed: 22890541
Antiviral Res. 2016 Oct;134:236-243
pubmed: 27659398
Nat Prod Res. 2022 Jun;36(12):3149-3152
pubmed: 34176386
Inflammopharmacology. 2020 Oct;28(5):1153-1161
pubmed: 32803479
Antiviral Res. 2011 Jan;89(1):83-8
pubmed: 21095205
Molecules. 2020 Apr 16;25(8):
pubmed: 32316274
Pharmaceuticals (Basel). 2021 Feb 08;14(2):
pubmed: 33567501
Evid Based Complement Alternat Med. 2011;2011:253643
pubmed: 20008902
J Sci Food Agric. 2018 Feb;98(3):833-848
pubmed: 28758221
Front Pharmacol. 2015 Mar 02;6:36
pubmed: 25784877
Pharmaceuticals (Basel). 2021 Mar 09;14(3):
pubmed: 33803165
Iran J Microbiol. 2014 Jun;6(3):149-55
pubmed: 25870747
Foods. 2021 Jul 30;10(8):
pubmed: 34441545
Pharmazie. 2008 Feb;63(2):160-3
pubmed: 18380405

Auteurs

Valentina Noemi Madia (VN)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Walter Toscanelli (W)

Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Daniela De Vita (D)

Department of Environmental Biology, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Marta De Angelis (M)

Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Antonella Messore (A)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Davide Ialongo (D)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Luigi Scipione (L)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Valeria Tudino (V)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Felicia Diodata D'Auria (FD)

Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Roberto Di Santo (R)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Stefania Garzoli (S)

Department of Drug Chemistry and Technologies, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Annarita Stringaro (A)

National Center for Drug Research and Evaluation, Italian National Institute of Health, V.le Regina Elena, 299, I-00161 Rome, Italy.

Marisa Colone (M)

National Center for Drug Research and Evaluation, Italian National Institute of Health, V.le Regina Elena, 299, I-00161 Rome, Italy.

Magda Marchetti (M)

National Centre for Innovative Technologies in Public Health, Italian National Institute of Health, V.le Regina Elena, 299, I-00161 Rome, Italy.

Fabiana Superti (F)

National Centre for Innovative Technologies in Public Health, Italian National Institute of Health, V.le Regina Elena, 299, I-00161 Rome, Italy.

Lucia Nencioni (L)

Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Roberta Costi (R)

Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, I-00185 Rome, Italy.

Articles similaires

Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections
Humans Carcinoma, Hepatocellular Liver Neoplasms Aged United States

Aminoacid functionalised magnetite nanoparticles Fe

Spoială Angela, Motelica Ludmila, Ilie Cornelia-Ioana et al.
1.00
Magnetite Nanoparticles Tryptophan Biocompatible Materials Microbial Sensitivity Tests Humans

Classifications MeSH